DEC 02, 2020 9:37 AM PST

Investigating the Active Components of an Herbal Mushroom

WRITTEN BY: Jasper Cantrell

When people think of traditional medicine, often what comes to mind are the old herbal medical practices in Asian countries. However, old Europe once had similar practices and used many natural remedies.

One of the more common ingredients in European herbal remedies was a mushroom called Fomitopsis officinalis, or agarikon. Commonly found on the trunks of fir trees, it was used to treat everything from inflammation, rheumatism, dizziness, and cancer. Its use declined after an extract of it, called agaricin, showed promising therapeutic effects across a range of ailments.

Fomitopsis officinalis is now an incredibly rare mushroom. It has been under strict regulation since the 1980s after its use as an herbal remedy combined with deforestation of its natural habitat nearly drove it to extinction. In a new study, a team from the Jagiellonian University Medical College in Poland managed to secure a sample to identify this nearly extinct fungus’ biologically active components.

This study focused on identifying the active biological components, as other studies have identified other common compounds such as polysaccharides or terpenoids. They used analytical methods such as reversed-phase high-performance liquid chromatography (RP-HPLC) and atomic absorption spectroscopy with flame atomization (F-AAS).

Analysis of the makeup of F. officinalis was broken down into the fruiting body (what we think of as a classic mushroom) and an in vitro liquid line. The fruiting body was found to have more indole compounds (i.e., tryptophan and melatonin). While both the fruiting body and liquid culture had similar phenol (ring-shaped compounds) and other biological compound profiles. Both also showed antioxidant activity and anti-cancer activity, with the liquid culture having the most potent effect.

This study analyzed and identified several biological components of the mushroom Fomitopsis officinalis. Phenols, one of the primary parts of F. officinalis, are known to be some of the most effective antioxidants in nature. F. officinalis also suppressed cancer cell line growth, although the team could not delve into how this activity was conducted. This was a quick but interesting study that revealed some of this rare mushroom’s active components and how it may work in some therapeutic cases.

The study concludes, “fruiting bodies may contribute to the antioxidant and antiproliferative effects. The results of this research study, especially the FTIR analyses, showed several similarities in the composition of both extracts; this implies that not only fruiting bodies but also mycelia obtained from in vitro cultures can synthesize metabolites with potential medicinal, pharmaceutical, and cosmetological use.”

Sources: Nature Scientific Reports, TEDMED

About the Author
Bachelors of the Sciences
Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
DEC 15, 2021
Health & Medicine
Limonene: The Terpene to Deploy against Cancer
DEC 15, 2021
Limonene: The Terpene to Deploy against Cancer
Limonene is one of the most well-known cannabis terpenes, and it’s getting increased attention in the medical prof ...
JAN 07, 2022
Cancer
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
JAN 07, 2022
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
The blood-brain barrier (BBB) describes the complex vasculature network that delivers oxygen and nutrients to the brain. ...
JAN 25, 2022
Immunology
Lung Cancer Vaccine Goes on Trial
JAN 25, 2022
Lung Cancer Vaccine Goes on Trial
Vaccines have been a hot topic in the headlines—blueprints that train the immune system to target a disease-causin ...
FEB 04, 2022
Drug Discovery & Development
A microbiome-based therapy for cancer patients is a step closer to approval
FEB 04, 2022
A microbiome-based therapy for cancer patients is a step closer to approval
The French pharmaceutical company, MaaT Pharma, has announced positive data showing the effectiveness of ...
MAR 07, 2022
Genetics & Genomics
Transcriptional Regulator BEND3 Found to Control Cell Differentiation
MAR 07, 2022
Transcriptional Regulator BEND3 Found to Control Cell Differentiation
Like embryonic stem cells, pluripotent stem cells can also specialize into any type of cell in the body by following bio ...
MAR 16, 2022
Cell & Molecular Biology
Remember Memorizing the Krebs Cycle? An Alternate Version Was Just Discovered
MAR 16, 2022
Remember Memorizing the Krebs Cycle? An Alternate Version Was Just Discovered
If you took biochemistry classes, chances are good you remember memorizing the Krebs cycle, a well-known metabolic pathw ...
Loading Comments...